Administered paricalcitol dose and survival in hemodialysis patients: A marginal structural model analysis

  • PARICALCITOL DOSE AND SURVIVAL IN HEMODIALYSIS PATIENTS
  • Jessica E Miller, Miklos Z Molnar, Csaba P Kovesdy, Joshua J Zaritsky, Elani Streja, Isidro Salusky, Onyebuchi A Arah, Kamyar Kalantar-Zadeh
  • Pharmacoepidemiology and Drug Safety, September 2012, Wiley
  • DOI: 10.1002/pds.3349

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/pds.3349

The following have contributed to this page: Dr. Miklos Z Molnar and Professor Kamyar Kalantar-Zadeh